SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

Share Price is delayed by 15 minutes
Get Live Data
1.24    0.00 (0.00%)
Bid:
1.20
Ask:
1.28
Spread: 0.08 (6.667%)
Market Cap: $21.21m
JPEL Live PriceLast checked at - London Stock Exchange

Intraday Jpel Priv Eqty Share Chart

Tender Offer

10 Nov 2011 09:41

RNS Number : 8545R
J.P. Morgan Private Equity Ltd
10 November 2011
 



 

J.P. MORGAN PRIVATE EQUITY LIMITEDANNOUNCES INTENT TO OPERATE TENDER FACILITY FOR THE PERIODENDING 31 DECEMBER 2011

 

* * *

 

GUERNSEY, 10 NOVEMBER 2011

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is pleased to announce its intent to make a tender offer to purchase up to 3% of US$ Equity Shares, 2013 ZDP Shares and 2015 ZDP Shares, respectively, currently in issue (excluding shares held in treasury) (the "Shares").

 

JPEL's Board of Directors intends to make a formal announcement regarding the operation of the Company's tender facility in due course. Shares will be tendered based on the prevailing net asset value (NAV) as at 31 December 2011.

 

"Returning capital to shareholders at prevailing NAV is a significant priority and is a direct result of the Company's strong balance sheet and distribution activity." said Trevor Ash, JPEL's Chairman. "When distribution activity is sufficient, we look to reward shareholders with the ability to periodically tender shares at NAV. JPEL is the only listed private equity fund to offer such a tender facility. Since its IPO in 2005, JPEL has returned over $127 million to shareholders through redemptions, tenders and market buy backs."

 

The terms and conditions of the tender offer and instructions on how shareholders may participate in the tender offer will be set forth in a Circular to be published once the Company makes a formal announcement. The Company will hold Shares tendered in treasury, subject to compliance with all regulatory limits. At this time, no tender will be made for 2017 ZDP Shares as there is currently no shareholder authority for the Company to tender 2017 ZDP Shares. JPEL intends to seek the authority to tender up to 15 per cent. of all classes of shares currently in issue at the Company's next annual general meeting to be held in 2012.

 

JPEL remains focused on maintaining a strong balance sheet. As such, the operation of the tender facility will be subject to various factors including positive distribution activity from the Company's underlying private equity investments and the overall health of the global economy. Therefore, JPEL's Board of Directors and the Manager will continue to monitor cash flows from JPEL's underlying investments in order to determine timing and appropriate levels for future tender offers. JPEL's Board of Directors continues to believe that its highest obligation during periods of economic uncertainty is to keep the Company healthy and strong for the future.

 

* * *

ENQUIRIES

 

J.P. Morgan Private Equity Limited 

Troy Duncan: Tel (Direct): +44 207 742 3032 (troy.duncan@jpmorgan.com)

Gregory Getschow: Tel (Direct): +1 212 648 1150 (gregrory.getschow@jpmorgan.com)

Rosemary DeRise: Tel (Direct): +1 212 648 2980 (rosemary.derise@jpmorgan.com)

Samantha Ladd: Tel (Direct): +1 212 648 2982 (samantha.ladd@jpmorgan.com)

 

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ, JPSZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

 

END

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TENEANFEFDNFFEF
Date   Source Headline
9th Nov 20224:11 pmRNS2022 AGM CIRCULAR
27th Oct 20226:26 pmRNSNet Asset Value - September 2022
23rd Sep 20224:54 pmRNSAnnual Financial Report - 30 June 2022
13th Sep 20223:03 pmRNSNet Asset Value(s) - June 2022
13th Jul 202211:36 amRNSNet Asset Value(s) - May 2022
6th Jul 20224:26 pmRNSHolding(s) in Company
6th Jul 20227:00 amRNSUpdate to Shareholders
23rd Jun 20225:10 pmRNSNet Asset Value(s) - April 2022
17th May 20227:00 amRNSNet Asset Value(s) - March 2022
11th May 202211:27 amRNSNet Asset Value - February 2022
6th May 20227:00 amRNSNet Asset Value - January 2022
5th May 20225:39 pmRNSHolding(s) in Company
3rd May 20227:00 amRNSPortfolio Update
11th Apr 202212:34 pmRNSCompletion of Tenth Mandatory Redemption
4th Apr 20227:00 amRNSTenth Mandatory Redemption
17th Mar 20225:35 pmRNSHalf-year Report - 31 December 2021
7th Mar 20229:44 amRNSNet Asset Value - December 2021
19th Jan 20221:47 pmRNSNet Asset Value - November 2021
22nd Dec 20214:24 pmRNSNet Asset Value - October 2021
23rd Nov 20212:13 pmRNSAGM Results 2021
16th Nov 20214:42 pmRNSNet Asset Value - September 2021
3rd Nov 202112:29 pmRNSNet Asset Value - August 2021
2nd Nov 20211:49 pmRNS2021 AGM CIRCULAR
28th Oct 20217:00 amRNSHolding(s) in Company
26th Oct 20214:03 pmRNSHolding(s) in Company
25th Oct 20215:52 pmRNSNet Asset Value - July 2021
30th Sep 20218:27 amRNSAnnual Financial Report - 30 June 2021
12th Aug 20217:00 amRNSCompletion of Ninth Mandatory Redemption
5th Aug 20217:00 amRNSNinth Mandatory Redemption
4th Aug 20213:45 pmRNSNet Asset Value - June 2021
23rd Jul 20213:52 pmRNSLargest Investment Sale & 9th Mandatory Redemption
21st Jul 20213:16 pmRNSNet Asset Value - May 2021
3rd Jun 20213:59 pmRNSNet Asset Value - April 2021
14th May 20213:52 pmRNSNet Asset Value - March 2021
19th Apr 20219:34 amRNSNet Asset Value - February 2021
6th Apr 20217:00 amRNSHolding(s) in Company
1st Apr 20214:21 pmRNSHolding(s) in Company
31st Mar 20215:17 pmRNSNet Asset Value - January 2021
17th Mar 20215:13 pmRNSHalf-year Report - 31 December 2020
24th Feb 20214:35 pmRNSNet Asset Value - December 2020
28th Jan 20215:27 pmRNSHolding(s) in Company
25th Jan 20214:49 pmRNSHolding(s) in Company
15th Jan 20212:01 pmRNSNet Asset Value - November 2020
14th Jan 20213:30 pmRNSHolding(s) in Company
30th Dec 20207:00 amRNSCompletion of 8th Mandatory Redemption
17th Dec 20207:00 amRNSLargest Investment & 8th Mandatory Redemption
11th Dec 20203:01 pmRNSNet Asset Value - October 2020
26th Nov 202010:43 amRNSAGM Results 2020
26th Nov 202010:16 amRNSAGM Results 2020
20th Nov 20207:00 amRNSNet Asset Value - September 2020

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.